ATE469915T1 - Antikörper gegen das meningokokken adhäsin app - Google Patents

Antikörper gegen das meningokokken adhäsin app

Info

Publication number
ATE469915T1
ATE469915T1 AT02790218T AT02790218T ATE469915T1 AT E469915 T1 ATE469915 T1 AT E469915T1 AT 02790218 T AT02790218 T AT 02790218T AT 02790218 T AT02790218 T AT 02790218T AT E469915 T1 ATE469915 T1 AT E469915T1
Authority
AT
Austria
Prior art keywords
app
disclosed
adhesin
meningococc
antibodies against
Prior art date
Application number
AT02790218T
Other languages
German (de)
English (en)
Inventor
Maria Arico
Maurizio Comanducci
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0118401A external-priority patent/GB0118401D0/en
Priority claimed from GBGB0121591.2A external-priority patent/GB0121591D0/en
Priority claimed from GB0211025A external-priority patent/GB0211025D0/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE469915T1 publication Critical patent/ATE469915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02790218T 2001-07-27 2002-07-26 Antikörper gegen das meningokokken adhäsin app ATE469915T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0118401A GB0118401D0 (en) 2001-07-27 2001-07-27 Meningococcus data
GBGB0121591.2A GB0121591D0 (en) 2001-09-06 2001-09-06 Hybrid and tandem expression of neisserial proteins
GB0211025A GB0211025D0 (en) 2002-05-14 2002-05-14 Meningococcus adhesins
PCT/IB2002/003396 WO2003010194A2 (fr) 2001-07-27 2002-07-26 Adhesines des meningocoques

Publications (1)

Publication Number Publication Date
ATE469915T1 true ATE469915T1 (de) 2010-06-15

Family

ID=27256234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790218T ATE469915T1 (de) 2001-07-27 2002-07-26 Antikörper gegen das meningokokken adhäsin app

Country Status (14)

Country Link
US (3) US20050232936A1 (fr)
EP (2) EP2248822B1 (fr)
JP (3) JP4592284B2 (fr)
AT (1) ATE469915T1 (fr)
AU (1) AU2002355197A1 (fr)
BR (1) BR0211494A (fr)
CA (1) CA2452836C (fr)
CY (2) CY1111715T1 (fr)
DE (1) DE60236596D1 (fr)
DK (1) DK2248822T3 (fr)
ES (1) ES2615362T3 (fr)
MX (1) MXPA04000653A (fr)
PT (1) PT2248822T (fr)
WO (1) WO2003010194A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
MX343752B (es) 1998-05-01 2016-11-22 Novartis Vaccines & Diagnostics Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
NZ571167A (en) 1999-04-30 2010-05-28 Novartis Vaccines & Diagnostic Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
EP1179072A2 (fr) 1999-05-19 2002-02-13 Chiron S.P.A. Compositions a base de combinaisons de neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2270030E (pt) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Expressão heteróloga de proteínas de neisseria
MXPA03000822A (es) 2000-07-27 2004-11-01 Childrens Hosp & Res Ct Oak Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
ES2615362T3 (es) 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
CN1674933B (zh) * 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
EP2351579B1 (fr) 2002-10-11 2016-09-21 Novartis Vaccines and Diagnostics S.r.l. Vaccins incluant du NadA oligomère de la méningococcie pour une protection élargie contre des lignées hypervirulentes
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
DK1587537T3 (da) 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
GB0315022D0 (en) * 2003-06-26 2003-07-30 Chiron Srl Virulence-associated adhesins
ES2397923T3 (es) * 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0415160D0 (en) * 2004-07-06 2004-08-11 Chiron Srl Inhibitors of bacterial infection
CN101107007B (zh) 2005-01-27 2011-08-17 奥克兰儿童医院及研究中心 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
CA2632434A1 (fr) * 2005-12-06 2007-06-14 Universita Degli Studi Di Padova Methodes et compositions relatives a des adhesines servant d'adjuvants
MX2011003381A (es) * 2008-09-30 2011-04-21 Abbott Lab Metodo mejorado para despliegue de arn.
EP2443250B8 (fr) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA Dosages haut débit de bactéricides opsoniques et dépendant d'anticorps à médiation par le complément
CA2810971C (fr) * 2010-09-10 2020-11-03 Novartis Ag Developpements apportes a des vesicules membranaires externes meningococciques
ES2847923T3 (es) 2012-06-14 2021-08-04 Glaxosmithkline Biologicals Sa Vacunas contra el meningococo del serogrupo X
CN104736563A (zh) 2012-07-27 2015-06-24 国家健康与医学研究院 Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附
TW201620927A (zh) * 2014-02-24 2016-06-16 葛蘭素史密斯克藍生物品公司 Ｕｓｐａ２蛋白質構築體及其用途
EP3263695A1 (fr) 2016-06-29 2018-01-03 GlaxoSmithKline Biologicals SA Compositions immunogènes
GB202115151D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Methods
US20250223319A1 (en) * 2022-03-31 2025-07-10 The University Of Queensland Improved chimeric polypeptides and uses thereof

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU545912B2 (en) 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
BR8202422A (pt) 1981-04-29 1983-04-12 Biogen Nv Vetor de clonacao de bacillus processo para sua construcao molecula de dna recombinante processo para sua construcao e processo para a producao de um polipeptidio
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
JPS59166086A (ja) 1983-03-09 1984-09-19 Teruhiko Beppu 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
JPS59205983A (ja) 1983-04-28 1984-11-21 ジエネツクス・コ−ポレイシヨン 異種遺伝子を原核微生物で発現させる方法
US4663280A (en) 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
US4689406A (en) 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6054685A (ja) 1983-09-02 1985-03-29 Suntory Ltd 改良発現ベクタ−およびその利用
EP0136907A3 (fr) 1983-10-03 1986-12-30 Genentech, Inc. Système de contrôle d'expression xenogénésiaque, méthode pour son utilisation, vecteurs d'expression le contenant, cellules transformées par ceux-ci et protéines hétérologues produites par ceux-ci
US4738921A (en) 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4745056A (en) 1984-10-23 1988-05-17 Biotechnica International, Inc. Streptomyces secretion vector
US4865974A (en) 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
JPS63123383A (ja) 1986-11-11 1988-05-27 Mitsubishi Kasei Corp ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
EP0436537A4 (en) 1988-01-29 1992-04-08 Chiron Corporation Recombinant cmv neutralizing proteins
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US6165747A (en) * 1993-12-30 2000-12-26 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6610539B1 (en) 1997-07-10 2003-08-26 Genesense Technologies, Inc. Antisense oligonucleotide sequences as inhibitors of microorganisms
US6300318B1 (en) 1997-09-16 2001-10-09 Peter E. Nielsen Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor
BR9813930A (pt) 1997-11-06 2006-12-19 Chiron Spa antìgeno neisserial
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ATE446368T1 (de) 1998-01-14 2009-11-15 Novartis Vaccines & Diagnostic Antigene aus neisseria meningitidis
ATE375393T1 (de) 1998-01-30 2007-10-15 Asubio Pharma Co Ltd Verfahren zur herstellung eines peptids mittels eines hilfspeptids
GB9808866D0 (en) 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
MX343752B (es) 1998-05-01 2016-11-22 Novartis Vaccines & Diagnostics Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
ES2278446T3 (es) 1998-05-29 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Vacunas combinadas b/c contra la meningitis.
GB9818004D0 (en) 1998-08-18 1998-10-14 Smithkline Beecham Biolog Novel compounds
JP4673974B2 (ja) 1998-09-30 2011-04-20 ワイス・ホールディングズ・コーポレイション アジュバントとしての変異コレラホロトキシン
BR9914374A (pt) 1998-10-09 2002-09-17 Chiron Corp Sequências genÈmicas de neisseria e métodos para seu uso
NZ571167A (en) 1999-04-30 2010-05-28 Novartis Vaccines & Diagnostic Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
ES2323845T3 (es) 1999-04-30 2009-07-27 Novartis Vaccines And Diagnostics, Inc. Secuencias genomicas de neisseria y procedimientos de uso.
EP1179072A2 (fr) 1999-05-19 2002-02-13 Chiron S.P.A. Compositions a base de combinaisons de neisseria
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
ATE460484T1 (de) 1999-11-29 2010-03-15 Novartis Vaccines & Diagnostic 85 kda antigen von neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
ES2588917T3 (es) * 2000-01-17 2016-11-07 Glaxosmithkline Biologicals Sa Vacuna de VME suplementada contra meningococo
PT2270030E (pt) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Expressão heteróloga de proteínas de neisseria
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
CN100350972C (zh) 2001-07-26 2007-11-28 启龙股份公司 含有铝佐剂和组氨酸的疫苗
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2615362T3 (es) 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
EP2351579B1 (fr) * 2002-10-11 2016-09-21 Novartis Vaccines and Diagnostics S.r.l. Vaccins incluant du NadA oligomère de la méningococcie pour une protection élargie contre des lignées hypervirulentes
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
ES2397923T3 (es) * 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos

Also Published As

Publication number Publication date
EP1412381B1 (fr) 2010-06-02
BR0211494A (pt) 2004-08-17
JP2005503785A (ja) 2005-02-10
AU2002355197A1 (en) 2003-02-17
JP4902678B2 (ja) 2012-03-21
ES2615362T3 (es) 2017-06-06
JP4592284B2 (ja) 2010-12-01
EP2248822A3 (fr) 2011-04-13
WO2003010194A3 (fr) 2003-10-02
EP1412381A2 (fr) 2004-04-28
CY1118628T1 (el) 2017-07-12
JP2010268801A (ja) 2010-12-02
CA2452836C (fr) 2012-11-27
DK2248822T3 (en) 2017-02-13
WO2003010194A2 (fr) 2003-02-06
US20140294884A1 (en) 2014-10-02
EP2248822A2 (fr) 2010-11-10
US9249197B2 (en) 2016-02-02
MXPA04000653A (es) 2004-11-22
CY1111715T1 (el) 2015-10-07
US20100221256A1 (en) 2010-09-02
DE60236596D1 (de) 2010-07-15
US20050232936A1 (en) 2005-10-20
PT2248822T (pt) 2017-02-14
EP2248822B1 (fr) 2016-11-23
JP2009148279A (ja) 2009-07-09
CA2452836A1 (fr) 2003-02-06

Similar Documents

Publication Publication Date Title
DE60236596D1 (de) Antikörper gegen das meningokokken adhäsin app
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
ATE318890T1 (de) Bakterielle wirtstämme
PL374782A1 (en) Animal protein free media for cultivation of cells
AU2003274331A1 (en) ULTRA-LOW LOADINGS OF Au FOR STAINLESS STEEL BIPOLAR PLATES
WO2007109430A3 (fr) Interface utilisateur et procédé associé
WO2005110453A3 (fr) Clivage du vegf et du récepteur du vegf par mt-sp1 de type sauvage et mutant
DE69840165D1 (de) Genkonstrukt das für ein heterologes "prodrug"-aktivierendes enzym und für ein zellgerichtes teil kodiert
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
DE60211119D1 (de) Kultivierung von crypthecodinium cohnii und abstammenden microorganismen
ATE459703T1 (de) Neuer brevibacillus choshinensis sowie verfahren zur herstellung von protein unter verwendung der mikrobe als wirt
ATE357458T1 (de) Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium
AU2002359244A1 (en) Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
BR0312700A (pt) Hsp70 de arthrobacter
AU2003256996A1 (en) Thermostable protease with altered cleavage specificity
DK0941241T3 (da) Bordetella-stamme, som udtrykker hybridet FHA
DE60127381D1 (de) Flavobakterium heparinum expressions-system
ATE509114T1 (de) Ethanolherstellung
AU2003903348A0 (en) Grass Growing Superstrate & Methods of Use
DE69935323D1 (de) Moraxella catharralis proteine
WO2003008568A3 (fr) Milieu de culture pour cultiver des champignons filamenteux
EP1449427A4 (fr) Bouture racinee et procede d'inoculation de bouture racinee avec une souche microbienne
TR200201815U (tr) "Sabit kendinden musluklu basınç düzenleyicisi"
WO2004067718A3 (fr) Mutants de bacteries de la tuberculose depourvus d'activite necrosante
EP1144588A3 (fr) Souches de bacteries lactiques, leur procede de culture et leurs applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties